Introduction of the 4-(4-bromophenyl)benzenesulfonyl group to hydrazide analogs of Ilomastat leads to potent gelatinase B (MMP-9) inhibitors with improved selectivity
Hydrazide derivatives of Ilomastat, carrying either aryl groups or distinct alkyl and arylsulfonyl moieties were synthesized and evaluated for their MMP inhibitory activity. Potent and selective MMP-9 inhibition (IC 50 = 3 nM) was observed for compound 3m (arylsulfonyl group: 4-(4-Br–C 6H 4)–C 6H 4–...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry 2008-09, Vol.16 (18), p.8745-8759 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Hydrazide derivatives of Ilomastat, carrying either aryl groups or distinct alkyl and arylsulfonyl moieties were synthesized and evaluated for their MMP inhibitory activity. Potent and selective MMP-9 inhibition (IC
50
=
3
nM) was observed for compound
3m (arylsulfonyl group: 4-(4-Br–C
6H
4)–C
6H
4–SO
2–). Interaction with the S
2 enzyme subsite is mainly responsible for the inhibitory properties of this derivative as confirmed by molecular docking computation. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2008.07.041 |